FDA approved CYTK's Myqorzo for oHCM. It reduces heart's pumping ability, has a warning for heart failure and expected to ...

The FDA has approved Myqorzo for the treatment of adults with symptomatic oHCM to improve functional capacity and symptoms.

The US Food and Drug Administration has approved aficamten (Myqorzo), an allosteric cardiac myosin inhibitor, for adults with ...

Scientists have developed a simple blood test that can predict which heart disease patients face the greatest risk of ...

New research suggests that regular aerobic exercise doesn’t just benefit the heart muscle, but subtly rewires the nerves that control how the heart works. Regular physical activity does more than ...

David C Gaze A marathon pushes the human body close to its limits. Legs tire, lungs burn, and the heart works hard for hours ...

Mark King has worked tirelessly since his son's tragic death and now wants to set up a unique centre in his name ...

A marathon pushes the human body close to its limits. Legs tire, lungs burn and the heart works hard for hours on end. For years, that strain has raised an uncomfortable question: does running 26 ...

A marathon pushes the human body close to its limits. Legs tire, lungs burn and the heart works hard for hours on end. For ...

Withdrawn to 2026, one thing is indisputable: preventive healthcare is not just an alternative anymore; it's the wisest ...

Independent analysis examines Fridays' published TRT program structure, delivery format options, and what clinical research indicates for men evaluating prescription testosterone pathways heading into ...